Regulation of viral replication, apoptosis and pro-inflammatory responses by 17-aag during chikungunya virus infection in macrophages

Viruses

Volumn 9, Issue 1, 2017, Pages

  Nayak, Tapas K ^a   Mamidi, Prabhudutta ^b   Kumar, Abhishek ^b   Singh, Laishram Pradeep K ^a,c   Sahoo, Subhransu S ^a   Chattopadhyay, Soma ^b   Chattopadhyay, Subhasis ^a  

^a NATIONAL INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

^b INSTITUTE OF LIFE SCIENCES   (India)

^c UNIVERSITY OF KALYANI   (India)

Author keywords

17 AAG; Alphavirus; Apoptosis; Chikungunya virus; HSP90; Macrophage; MHC; TNF

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CD86 ANTIGEN; INTERLEUKIN 6; LIPOCORTIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TANESPIMYCIN; TUMOR NECROSIS FACTOR; BENZOQUINONE DERIVATIVE; CYTOKINE; MACROCYCLIC LACTAM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHIKUNGUNYA; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; RAW 264.7 CELL LINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL PLAQUE ASSAY; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; CHIKUNGUNYA VIRUS; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); VIROLOGY;

ANIMALS; APOPTOSIS; BENZOQUINONES; BLOTTING, WESTERN; CHIKUNGUNYA VIRUS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LACTAMS, MACROCYCLIC; MACROPHAGES; MICE; RAW 264.7 CELLS; VIRAL PLAQUE ASSAY; VIRUS REPLICATION;

EID: 85009812429     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v9010003     Document Type: Article

References (90)

1. Khatun, S.; Chakraborty, A.; Rahman, M.; Nasreen Banu, N.; Rahman, M.M.; Hasan, S.M.; Luby, S.P.; Gurley, E.S. An outbreak of chikungunya in rural bangladesh, 2011. PLoS Negl. Trop. Dis. 2015, 9, e0003907. [CrossRef] [PubMed]
2. Kosasih, H.; de Mast, Q.; Widjaja, S.; Sudjana, P.; Antonjaya, U.; Ma’roef, C.; Riswari, S.F.; Porter, K.R.; Burgess, T.H.; Alisjahbana, B.; et al. Evidence for endemic chikungunya virus infections in bandung, indonesia. PLoS Negl. Trop. Dis. 2013, 7, e2483. [CrossRef] [PubMed]
3. Powers, A.M.; Logue, C.H. Changing patterns of chikungunya virus: Re-emergence of a zoonotic arbovirus. J. Gen. Virol. 2007, 88, 2363-2377. [CrossRef] [PubMed]
4. Rodriguez-Barraquer, I.; Solomon, S.S.; Kuganantham, P.; Srikrishnan, A.K.; Vasudevan, C.K.; Iqbal, S.H.; Balakrishnan, P.; Solomon, S.; Mehta, S.H.; Cummings, D.A. The hidden burden of dengue and chikungunya in chennai, India. PLoS Negl. Trop. Dis. 2015, 9, e0003906. [CrossRef] [PubMed]
5. Robinson, M.C. An epidemic of virus disease in southern province, tanganyika territory, in 1952-53. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 1955, 49, 28-32. [CrossRef]
6. Schwartz, O.; Albert, M.L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 2010, 8, 491-500. [CrossRef] [PubMed]
7. Thiberville, S.D.; Boisson, V.; Gaudart, J.; Simon, F.; Flahault, A.; de Lamballerie, X. Chikungunya fever: A clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl. Trop. Dis. 2013, 7, e2004. [CrossRef] [PubMed]
8. Mohd Zim, M.A.; Sam, I.C.; Omar, S.F.; Chan, Y.F.; AbuBakar, S.; Kamarulzaman, A. Chikungunya infection in Malaysia: Comparison with dengue infection in adults and predictors of persistent arthralgia. J. Clin. Virol. 2013, 56, 141-145. [CrossRef] [PubMed]
9. Borgherini, G.; Poubeau, P.; Staikowsky, F.; Lory, M.; le Moullec, N.; Becquart, J.P.; Wengling, C.; Michault, A.; Paganin, F. Outbreak of chikungunya on reunion island: Early clinical and laboratory features in 157 adult patients. Clin. Infect. Dis. 2007, 44, 1401-1407. [CrossRef] [PubMed]
10. Maiti, C.R.; Mukherjee, A.K.; Bose, B.; Saha, G.L. Myopericarditis following Chikungunya virus infection. J. Indian Med. Assoc. 1978, 70, 256-258. [PubMed]
11. Mittal, A.; Mittal, S.; Bharati, M.J.; Ramakrishnan, R.; Saravanan, S.; Sathe, P.S. Optic neuritis associated with Chikungunya virus infection in South India. Arch. Ophthalmol. 2007, 125, 1381-1386. [CrossRef] [PubMed]
12. Lalitha, P.; Rathinam, S.; Banushree, K.; Maheshkumar, S.; Vijayakumar, R.; Sathe, P. Ocular involvement associated with an epidemic outbreak of chikungunya virus infection. Am. J. Ophthalmol. 2007, 144, 552-556. [CrossRef] [PubMed]
13. Solanki, B.S.; Arya, S.C.; Maheshwari, P. Chikungunya disease with nephritic presentation. Int. J. Clin. Pract. 2007, 61. [CrossRef] [PubMed]
14. Simon, F.; Paule, P.; Oliver, M. Chikungunya virus-induced myopericarditis: Toward an increase of dilated cardiomyopathy in countries with epidemics? Am. J. Trop. Med. Hyg. 2008, 78, 212-213. [PubMed]
15. Chusri, S.; Siripaitoon, P.; Hirunpat, S.; Silpapojakul, K. Case reports of neuro-Chikungunya in Southern Thailand. Am. J. Trop. Med. Hyg. 2011, 85, 386-389. [CrossRef] [PubMed]
16. Renault, P.; Solet, J.L.; Sissoko, D.; Balleydier, E.; Larrieu, S.; Filleul, L.; Lassalle, C.; Thiria, J.; Rachou, E.; de Valk, H.; et al. A major epidemic of Chikungunya virus infection on reunion island, France, 2005-2006. Am. J. Trop. Med. Hyg. 2007, 77, 727-731. [PubMed]
17. Thiboutot, M.M.; Kannan, S.; Kawalekar, O.U.; Shedlock, D.J.; Khan, A.S.; Sarangan, G.; Srikanth, P.; Weiner, D.B.; Muthumani, K. Chikungunya: A potentially emerging epidemic? PLoS Negl. Trop. Dis. 2010, 4, e623. [CrossRef] [PubMed]
18. Strauss, J.H.; Strauss, E.G. The alphaviruses: Gene expression, replication, and evolution. Microbiol. Rev. 1994, 58, 491-562. [PubMed]
19. Couderc, T.; Chretien, F.; Schilte, C.; Disson, O.; Brigitte, M.; Guivel-Benhassine, F.; Touret, Y.; Barau, G.; Cayet, N.; Schuffenecker, I.; et al. A mouse model for Chikungunya: Young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008, 4, e29. [CrossRef] [PubMed]
20. Fros, J.J.; Liu, W.J.; Prow, N.A.; Geertsema, C.; Ligtenberg, M.; Vanlandingham, D.L.; Schnettler, E.; Vlak, J.M.; Suhrbier, A.; Khromykh, A.A.; et al. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J. Virol. 2010, 84, 10877-10887. [CrossRef] [PubMed]
21. Kelvin, A.A.; Banner, D.; Silvi, G.; Moro, M.L.; Spataro, N.; Gaibani, P.; Cavrini, F.; Pierro, A.; Rossini, G.; Cameron, M.J.; et al. Inflammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity. PLoS Negl. Trop. Dis. 2011, 5, e1279. [CrossRef] [PubMed]
22. Kumar, S.; Jaffar-Bandjee, M.C.; Giry, C.; Connen de Kerillis, L.; Merits, A.; Gasque, P.; Hoarau, J.J. Mouse macrophage innate immune response to Chikungunya virus infection. Virol. J. 2012, 9. [CrossRef] [PubMed]
23. Priya, R.; Dhanwani, R.; Patro, I.K.; Rao, P.V.; Parida, M.M. Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation. Infect. Genet. Evol. 2013, 20, 396-406. [CrossRef] [PubMed]
24. Priya, R.; Patro, I.K.; Parida, M.M. TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus. Virus Res. 2014, 189, 194-205. [CrossRef] [PubMed]
25. Chirathaworn, C.; Poovorawan, Y.; Lertmaharit, S.; Wuttirattanakowit, N. Cytokine levels in patients with Chikungunya virus infection. Asian Pac. J. Trop. Med. 2013, 6, 631-634. [CrossRef]
26. Chow, A.; Her, Z.; Ong, E.K.; Chen, J.M.; Dimatatac, F.; Kwek, D.J.; Barkham, T.; Yang, H.; Renia, L.; Leo, Y.S.; et al. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J. Infect. Dis. 2011, 203, 149-157. [CrossRef] [PubMed]
27. Lohachanakul, J.; Phuklia, W.; Thannagith, M.; Thongsakulprasert, T.; Smith, D.R.; Ubol, S. Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia. J. Med. Virol. 2015, 87, 733-739. [CrossRef] [PubMed]
28. Phuklia, W.; Kasisith, J.; Modhiran, N.; Rodpai, E.; Thannagith, M.; Thongsakulprasert, T.; Smith, D.R.; Ubol, S. Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: A possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis. Virus Res. 2014, 177, 179-188. [CrossRef] [PubMed]
29. Reddy, V.; Mani, R.S.; Desai, A.; Ravi, V. Correlation of plasma viral loads and presence of Chikungunya igm antibodies with cytokine/chemokine levels during acute Chikungunya virus infection. J. Med. Virol. 2014, 86, 1393-1401. [CrossRef] [PubMed]
30. Ng, L.F.; Chow, A.; Sun, Y.J.; Kwek, D.J.; Lim, P.L.; Dimatatac, F.; Ng, L.C.; Ooi, E.E.; Choo, K.H.; Her, Z.; et al. Il-1beta, IL-6, and rantes as biomarkers of Chikungunya severity. PLoS ONE 2009, 4, e4261. [CrossRef] [PubMed]
31. Daley-Bauer, L.P.; Wynn, G.M.; Mocarski, E.S. Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity 2012, 37, 122-133. [CrossRef] [PubMed]
32. Pratheek, B.M.; Saha, S.; Maiti, P.K.; Chattopadhyay, S.; Chattopadhyay, S. Immune regulation and evasion of mammalian host cell immunity during viral infection. Indian J. Virol. 2013, 24, 1-15. [CrossRef] [PubMed]
33. Qin, X.; Yao, J.; Yang, F.; Nie, J.; Wang, Y.; Liu, P.C. Human immunodeficiency virus type 1 Nef in human monocyte-like cell line THP-1 expands treg cells via toll-like receptor 2. J. Cell. Biochem. 2011, 112, 3515-3524. [CrossRef] [PubMed]
34. Shi, C.; Pamer, E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11, 762-774. [CrossRef] [PubMed]
35. Veiga-Parga, T.; Sehrawat, S.; Rouse, B.T. Role of regulatory T cells during virus infection. Immunol. Rev. 2013, 255, 182-196. [CrossRef] [PubMed]
36. Her, Z.; Malleret, B.; Chan, M.; Ong, E.K.; Wong, S.C.; Kwek, D.J.; Tolou, H.; Lin, R.T.; Tambyah, P.A.; Renia, L.; et al. Active infection of human blood monocytes by chikungunya virus triggers an innate immune response. J. Immunol. 2010, 184, 5903-5913. [CrossRef] [PubMed]
37. Labadie, K.; Larcher, T.; Joubert, C.; Mannioui, A.; Delache, B.; Brochard, P.; Guigand, L.; Dubreil, L.; Lebon, P.; Verrier, B.; et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J. Clin. Invest. 2010, 120, 894-906. [CrossRef] [PubMed]
38. Gardner, J.; Anraku, I.; Le, T.T.; Larcher, T.; Major, L.; Roques, P.; Schroder, W.A.; Higgs, S.; Suhrbier, A. Chikungunya virus arthritis in adult wild-type mice. J. Virol. 2010, 84, 8021-8032. [CrossRef] [PubMed]
39. Hoarau, J.J.; Jaffar Bandjee, M.C.; Krejbich Trotot, P.; Das, T.; Li-Pat-Yuen, G.; Dassa, B.; Denizot, M.; Guichard, E.; Ribera, A.; Henni, T.; et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 2010, 184, 5914-5927. [CrossRef] [PubMed]
40. Arndt, V.; Rogon, C.; Hohfeld, J. To be, or not to be—Molecular chaperones in protein degradation. Cell. Mol. Life Sci. 2007, 64, 2525-2541. [CrossRef] [PubMed]
41. Ma, Y.; Hendershot, L.M. ER chaperone functions during normal and stress conditions. J. Chem. Neuroanat. 2004, 28, 51-65. [CrossRef] [PubMed]
42. McClellan, A.J.; Tam, S.; Kaganovich, D.; Frydman, J. Protein quality control: Chaperones culling corrupt conformations. Nat. Cell Biol. 2005, 7, 736-741. [CrossRef] [PubMed]
43. Welch, W.J. How cells respond to stress. Sci. Am. 1993, 268, 56-64. [CrossRef] [PubMed]
44. Sedger, L.; Ruby, J. Heat shock response to vaccinia virus infection. J. Virol. 1994, 68, 4685-4689. [PubMed]
45. Sullivan, C.S.; Pipas, J.M. The virus-chaperone connection. Virology 2001, 287, 1-8. [CrossRef] [PubMed]
46. Basha, W.; Kitagawa, R.; Uhara, M.; Imazu, H.; Uechi, K.; Tanaka, J. Geldanamycin, a potent and specific inhibitor of Hsp90, inhibits gene expression and replication of human cytomegalovirus. Antivir. Chem. Chemother. 2005, 16, 135-146. [CrossRef] [PubMed]
47. Dutta, D.; Bagchi, P.; Chatterjee, A.; Nayak, M.K.; Mukherjee, A.; Chattopadhyay, S.; Nagashima, S.; Kobayashi, N.; Komoto, S.; Taniguchi, K.; et al. The molecular chaperone heat shock protein-90 positively regulates rotavirus infectionx. Virology 2009, 391, 325-333. [CrossRef] [PubMed]
48. Geller, R.; Vignuzzi, M.; Andino, R.; Frydman, J. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 2007, 21, 195-205. [CrossRef] [PubMed]
49. Hu, J.; Seeger, C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 1996, 93, 1060-1064. [CrossRef] [PubMed]
50. Hung, J.J.; Chung, C.S.; Chang, W. Molecular chaperone Hsp90 is important for vaccinia virus growth in cells. J. Virol. 2002, 76, 1379-1390. [CrossRef] [PubMed]
51. Okamoto, T.; Nishimura, Y.; Ichimura, T.; Suzuki, K.; Miyamura, T.; Suzuki, T.; Moriishi, K.; Matsuura, Y. Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp 90. EMBO J. 2006, 25, 5015-5025. [CrossRef] [PubMed]
52. Sun, X.; Barlow, E.A.; Ma, S.; Hagemeier, S.R.; Duellman, S.J.; Burgess, R.R.; Tellam, J.; Khanna, R.; Kenney, S.C. Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proc. Natl. Acad. Sci. USA 2010, 107, 3146-3151. [CrossRef] [PubMed]
53. Zheng, Z.Z.; Miao, J.; Zhao, M.; Tang, M.; Yeo, A.E.; Yu, H.; Zhang, J.; Xia, N.S. Role of heat-shock protein 90 in hepatitis E virus capsid trafficking. J. Gen. Virol. 2010, 91, 1728-1736. [CrossRef] [PubMed]
54. Kowalczyk, A.; Guzik, K.; Slezak, K.; Dziedzic, J.; Rokita, H. Heat shock protein and heat shock factor 1 expression and localization in vaccinia virus infected human monocyte derived macrophages. J. Inflamm. 2005, 2. [CrossRef] [PubMed]
55. Das, I.; Basantray, I.; Mamidi, P.; Nayak, T.K.; Pratheek, B.M.; Chattopadhyay, S.; Chattopadhyay, S. Heat shock protein 90 positively regulates Chikungunya virus replication by stabilizing viral non-structural protein nsP2 during infection. PLoS ONE 2014, 9, e100531. [CrossRef] [PubMed]
56. Rathore, A.P.; Haystead, T.; Das, P.K.; Merits, A.; Ng, M.L.; Vasudevan, S.G. Chikungunya virus nsP3 and nsP4 interacts with Hsp-90 to promote virus replication: Hsp-90 inhibitors reduce CHIKV infection and inflammation in vivo. Antivir. Res. 2014, 103, 7-16. [CrossRef] [PubMed]
57. Agnew, E.B.; Wilson, R.H.; Grem, J.L.; Neckers, L.; Bi, D.; Takimoto, C.H. Measurement of the novel antitumor agent 17-(allylamino)-17-demethoxygeldanamycin in human plasma by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 2001, 755, 237-243. [CrossRef]
58. Chattopadhyay, S.; Kumar, A.; Mamidi, P.; Nayak, T.K.; Das, I.; Chhatai, J.; Basantray, I.; Bramha, U.; Maiti, P.K.; Singh, S.; et al. Development and characterization of monoclonal antibody against non-structural protein-2 of Chikungunya virus and its application. J. Virol. Methods 2014, 199, 86-94. [CrossRef] [PubMed]
59. Kumar, A.; Mamidi, P.; Das, I.; Nayak, T.K.; Kumar, S.; Chhatai, J.; Chattopadhyay, S.; Suryawanshi, A.R. A novel 2006 Indian outbreak strain of Chikungunya virus exhibits different pattern of infection as compared to prototype strain. PLoS ONE 2014, 9, e85714. [CrossRef] [PubMed]
60. Mishra, P.; Kumar, A.; Mamidi, P.; Kumar, S.; Basantray, I.; Saswat, T.; Das, I.; Nayak, T.K.; Chattopadhyay, S.; Subudhi, B.B.; et al. Inhibition of chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea(mbzm-n-ibt). Sci. Rep. 2016, 6. [CrossRef] [PubMed]
61. Sourisseau, M.; Schilte, C.; Casartelli, N.; Trouillet, C.; Guivel-Benhassine, F.; Rudnicka, D.; Sol-Foulon, N.; le Roux, K.; Prevost, M.C.; Fsihi, H.; et al. Characterization of reemerging Chikungunya virus. PLoS Pathog. 2007, 3, e89. [CrossRef] [PubMed]
62. Barber, G.N. Host defense, viruses and apoptosis. Cell Death Differ. 2001, 8, 113-126. [CrossRef] [PubMed]
63. Coulombe, F.; Jaworska, J.; Verway, M.; Tzelepis, F.; Massoud, A.; Gillard, J.; Wong, G.; Kobinger, G.; Xing, Z.; Couture, C.; et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity 2014, 40, 554-568. [CrossRef] [PubMed]
64. Krejbich-Trotot, P.; Denizot, M.; Hoarau, J.J.; Jaffar-Bandjee, M.C.; Das, T.; Gasque, P. Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses. FASEB J. 2011, 25, 314-325. [CrossRef] [PubMed]
65. He, K.; Zhou, H.R.; Pestka, J.J. Mechanisms for ribotoxin-induced ribosomal RNA cleavage. Toxicol. Appl. Pharmacol. 2012, 265, 10-18. [CrossRef] [PubMed]
66. Chen, W.; Foo, S.S.; Taylor, A.; Lulla, A.; Merits, A.; Hueston, L.; Forwood, M.R.; Walsh, N.C.; Sims, N.A.; Herrero, L.J.; et al. Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by Chikungunya virus infection. J. Virol. 2015, 89, 581-593. [CrossRef] [PubMed]
67. Deshmane, S.L.; Kremlev, S.; Amini, S.; Sawaya, B.E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interf. Cytokine Res. 2009, 29, 313-326. [CrossRef] [PubMed]
68. Aleyas, A.G.; George, J.A.; Han, Y.W.; Rahman, M.M.; Kim, S.J.; Han, S.B.; Kim, B.S.; Kim, K.; Eo, S.K. Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and-independent pathways. J. Immunol. 2009, 183, 2462-2474. [CrossRef] [PubMed]
69. Hansen, T.H.; Bouvier, M. MHC class I antigen presentation: Learning from viral evasion strategies. Nat. Rev. Immunol. 2009, 9, 503-513. [CrossRef] [PubMed]
70. Hegde, N.R.; Chevalier, M.S.; Johnson, D.C. Viral inhibition of MHC class II antigen presentation. Trends Immunol. 2003, 24, 278-285. [CrossRef]
71. Khan, N.; Gowthaman, U.; Pahari, S.; Agrewala, J.N. Manipulation of costimulatory molecules by intracellular pathogens: Veni, vidi, vici!! PLoS Pathog. 2012, 8, e1002676. [CrossRef] [PubMed]
72. Schulte, T.W.; Neckers, L.M. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to Hsp90 and shares important biologic activities with geldanamycin. Cancer Chemother. Pharmacol. 1998, 42, 273-279. [CrossRef] [PubMed]
73. Wikan, N.; Sakoonwatanyoo, P.; Ubol, S.; Yoksan, S.; Smith, D.R. Chikungunya virus infection of cell lines: Analysis of the east, central and south african lineage. PLoS ONE 2012, 7, e31102. [CrossRef] [PubMed]
74. Abraham, R.; Mudaliar, P.; Padmanabhan, A.; Sreekumar, E. Induction of cytopathogenicity in human glioblastoma cells by Chikungunya virus. PLoS ONE 2013, 8, e75854. [CrossRef] [PubMed]
75. Baer, A.; Lundberg, L.; Swales, D.; Waybright, N.; Pinkham, C.; Dinman, J.D.; Jacobs, J.L.; Kehn-Hall, K. Venezuelan equine encephalitis virus induces apoptosis through the unfolded protein response activation of EGR 1. J. Virol. 2016, 90, 3558-3572. [CrossRef] [PubMed]
76. Dhanwani, R.; Khan, M.; Bhaskar, A.S.; Singh, R.; Patro, I.K.; Rao, P.V.; Parida, M.M. Characterization of chikungunya virus infection in human neuroblastoma SH-SY5Y cells: Role of apoptosis in neuronal cell death. Virus Res. 2012, 163, 563-572. [CrossRef] [PubMed]
77. Way, S.J.; Lidbury, B.A.; Banyer, J.L. Persistent ross river virus infection of murine macrophages: An in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology 2002, 301, 281-292. [CrossRef] [PubMed]
78. Fujimoto, I.; Pan, J.; Takizawa, T.; Nakanishi, Y. Virus clearance through apoptosis-dependent phagocytosis of influenza a virus-infected cells by macrophages. J. Virol. 2000, 74, 3399-3403. [CrossRef] [PubMed]
79. Van den Berg, E.; van Woensel, J.B.; Bem, R.A. Apoptosis in pneumovirus infection. Viruses 2013, 5, 406-422. [CrossRef] [PubMed]
80. Deszcz, L.; Cencic, R.; Sousa, C.; Kuechler, E.; Skern, T. An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases. J. Virol. 2006, 80, 9619-9627. [CrossRef] [PubMed]
81. Deszcz, L.; Seipelt, J.; Vassilieva, E.; Roetzer, A.; Kuechler, E. Antiviral activity of caspase inhibitors: Effect on picornaviral 2A proteinase. FEBS Lett. 2004, 560, 51-55. [CrossRef]
82. Kim, M.S.; Lee, J.A.; Kim, K.H. Effects of a broad-spectrum caspase inhibitor, z-vad(ome)-fmk, on viral hemorrhagic septicemia virus (VHSV) infection-mediated apoptosis and viral replication. Fish Shellfish Immunol. 2016, 51, 41-45. [CrossRef] [PubMed]
83. Martin, U.; Jarasch, N.; Nestler, M.; Rassmann, A.; Munder, T.; Seitz, S.; Zell, R.; Wutzler, P.; Henke, A. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B 3. Apoptosi 2007, 12, 525-533. [CrossRef] [PubMed]
84. Benedict, C.A. Viruses and the TNF-related cytokines, an evolving battle. Cytokine Growth Factor Rev. 2003, 14, 349-357. [CrossRef]
85. Mogensen, T.H.; Paludan, S.R. Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol. Rev. 2001, 65, 131-150. [CrossRef] [PubMed]
86. Trinchieri, G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr. Opin. Immunol. 1997, 9, 17-23. [CrossRef]
87. Redpath, S.; Ghazal, P.; Gascoigne, N.R. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. 2001, 9, 86-92. [CrossRef]
88. Pratheek, B.M.; Suryawanshi, A.R.; Chattopadhyay, S.; Chattopadhyay, S. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8+ T cell response and advancement of epitope based immunotherapy for CHIKV infection. Infect. Genet. Evol. 2015, 31, 118-126. [CrossRef] [PubMed]
89. Georgakis, G.V.; Li, Y.; Rassidakis, G.Z.; Medeiros, L.J.; Younes, A. The Hsp90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of Alk expression. Exp. Hematol. 2006, 34, 1670-1679. [CrossRef] [PubMed]
90. Nimmanapalli, R.; O’Bryan, E.; Kuhn, D.; Yamaguchi, H.; Wang, H.G.; Bhalla, K.N. Regulation of 17-AAG-induced apoptosis: Role of Bcl-2, Bcl-XL, and bax downstream of 17-AAG-mediated down-regulation of Akt, Raf-1, and Src kinases. Blood 2003, 102, 269-275. [CrossRef] [PubMed]